Purchase of anti-infective medicines for systemic use

The bidder may be excluded if it, or a person in its management, administration or supervisory bodies or authorised to represent, control or make decisions for it, has a final conviction within the previous five years—or remains subject to an exclusion period—for participation in a criminal organisation, corruption, fraud, terrorist offences, money laundering or terrorist financing, child labour or human trafficking. Where permitted for this procurement, the bidder may provide evidence of measures taken to restore its reliability. Exclusion grounds also include breaches of tax or social security payment obligations, enabling a foreign national without legal grounds to stay in the country to work, or allowing violations of the applicable employment conditions, and circumstances in which awarding the contract would breach an international or Estonian government sanction. The notice sets the debt threshold at EUR 0; under the stated Estonian rules, a tax-debt certificate is not issued where the relevant debt is below EUR 100 or payment has been rescheduled. The applicable rules of the bidder’s country of establishment apply to foreign bidders.

For all 17 lots, the bidder must be entered in the relevant business register. The bidder must hold a valid wholesale medicines licence by the bid submission deadline; the contracting authority will verify this in the Medicines Agency register. The bid must include the completed Annex 1 technical description and detailed price offer for each lot bid for. The maximum price stated for each lot in Annex 1 must match the amount entered in the procurement system’s price form; VAT is added as required by law. Conditional bids are not permitted, and submitting a bid confirms acceptance of the procurement requirements. If requested, the bidder must promptly provide the manufacturer-issued summary of product characteristics or package leaflet in Estonian or English within the deadline set by the contracting authority. For medicines without a marketing authorisation, the bidder must hold an import permit issued by the Medicines Agency no later than the contract’s effective date and provide evidence on request; copies of marketing authorisations for authorised medicines must also be provided on request. Joint bidders must appoint an authorised representative and include the relevant power of attorney. Any information claimed as a trade secret must be identified and the claim justified; prices and price components, as well as other evaluated indicators for goods, may not be designated as trade secrets. The supplied document does not specify the detailed award-criteria scoring or weighting; check the official tender documents for those details.